Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degenerations.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00000145
What this trial is testing

Age-Related Eye Disease Study (AREDS)

Who this might be right for
Macular DegenerationCataractLens Opacities
National Eye Institute (NEI) 4,757
Not applicableUnknownNCT05342857
What this trial is testing

Maximum Treatment Interval With Aflibercept T&E

Who this might be right for
Neovascular Age-related Macular Degeneration
Shin Kong Wu Ho-Su Memorial Hospital 100
Not applicableStudy completedNCT00647439
What this trial is testing

Genetics and Markers of Degenerative and Inflammatory Eye Diseases

Who this might be right for
Diabetic RetinopathyAge-Related Macular Degeneration (AMD)Uveitis
National Eye Institute (NEI) 609
Not applicableStudy completedNCT06124677
What this trial is testing

Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments

Who this might be right for
Neovascular Age-related Macular Degeneration
Rigshospitalet, Denmark 46
Testing effectiveness (Phase 2)UnknownNCT06487039
What this trial is testing

Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
EyebioKorea, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07158775
What this trial is testing

Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Who this might be right for
Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Bionic Sight LLC 40
Not applicableStudy completedNCT05437302
What this trial is testing

Effectiveness of Prism Spectacles in Patients With Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Faisalabad 80
Early research (Phase 1)Study completedNCT05643118
What this trial is testing

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Olix Pharmaceuticals, Inc. 21
Not applicableLooking for participantsNCT05675150
What this trial is testing

Expressive Arts-based Intervention for Adults With Age-related Visual Impairment

Who this might be right for
Age-Related Macular Degeneration
The University of Hong Kong 154
Not applicableStudy completedNCT00831961
What this trial is testing

Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics

Who this might be right for
Age-related Macular Degeneration
Vanderbilt University 24
Not applicableStudy completedNCT02811692
What this trial is testing

Study for Collection of Aflibercept Data in Routine Practice

Who this might be right for
Eye Diseases
Bayer 425
Not applicableLooking for participantsNCT06536062
What this trial is testing

Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Not applicableStudy completedNCT05196139
What this trial is testing

Visual Outcome After Vitrectomy With Subretinal tPA Injection

Who this might be right for
Age-Related Macular Degeneration
Universitaire Ziekenhuizen KU Leuven 96
Not applicableStudy completedNCT02463344
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 11
Testing effectiveness (Phase 2)Study completedNCT01304693
What this trial is testing

ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 376
Early research (Phase 1)Looking for participantsNCT07594236
What this trial is testing

Phase 1 Study of C.001 in Retinal Degeneration

Who this might be right for
Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more
Cellio Therapeutics Inc 15
Not applicableStudy completedNCT07318428
What this trial is testing

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

Who this might be right for
Diabetic RetinopathyAge Related Macular DegenerationRetinal Vein Occlusion+2 more
Inje University 10
Not applicableStudy completedNCT04920071
What this trial is testing

Optimising Visual Acuity Measurement in Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 50
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Early research (Phase 1)WithdrawnNCT00726466
What this trial is testing

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationAMDCNV
Vitreous -Retina- Macula Consultants of New York
Next Page